Nikolai Bildzukewicz, MD
Surgery · Los Angeles, CANPI 1255547493
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $222,583 of the $318,717 with a category attached, or 69.8%. 18 manufacturers reported payments, led by Johnson & Johnson at 51.7% of the total. Reporting peaked in 2019 at $164,358 and has fallen 91.2% since, to $14,435 in 2025. Among surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 336 payments — averaging $948.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$165K
- Medical Device Business Services, Inc.$76K
- Intuitive Surgical$75K
- Endogastric Solutions, Inc$1K
- Enterra Medical, Inc.$445
- Medtronic$421
- plus $891 from 12 others
Across 3 payments — averaging $9698.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Davol Inc.$29K
What the payments were for
- Consulting fees$222,58370%
- Speaking & faculty fees$6,5002%
- Travel & lodging$19,0736%
- Food & beverage$11,5264%
- Education$59,00019%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 119 | $164,713 |
| Medical Device Business Services, Inc. | 74 | $76,197 |
| Intuitive Surgical | 96 | $74,865 |
| Endogastric Solutions, Inc | 12 | $1,186 |
| Enterra Medical, Inc. | 4 | $445 |
| Medtronic(2 entities) | 7 | $421 |
| Covidien LP | 4 | $321 |
| AbbVie | 5 | $120 |
| Lucid Diagnostics Inc. | 4 | $92 |
| W. L. Gore & Associates, Inc. | 2 | $81 |
| BD | 1 | $71 |
| TELA Bio, Inc. | 1 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $47 |
| Baxter Healthcare | 1 | $24 |
| Novocure Inc. | 1 | $22 |
| Medexus Pharma, Inc. | 1 | $22 |
| Acell, Inc. | 1 | $21 |
| Ambu Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINX Reflux Management System$183,957
- Da Vinci Surgical System$73,315
- ESOPHYX$773
- DA VINCI SP$243
- ENTERRA$154
- Bravo$124
- AbsorbaTack$116
How this compares
$318,717 in reported general payments places this provider in the 95th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 16 | $2,704 |
| Pantoprazole Sodium | 43 | $1,072 |
| Sucralfate | 19 | $410 |
| Ondansetron OdtOndansetron | 25 | $309 |
| Omeprazole | 33 | $189 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $120 |
Paid to pharmacies, not to this prescriber.
Other surgery in Los Angeles
- John LiphamLos Angeles$942K
- Caitlin HoughtonLos Angeles$569K
- Namir KatkhoudaLos Angeles$187K
- Jonathan SalutaLos Angeles$150K
- Raul RosenthalLos Angeles$147K
- Timothy ChuterSan Francisco$8.8M
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.